Myolex, INC.
At a glance
Employees1-19
In business sinceNot reported
HeadquartersBrookline, MA
US patents4
SAM.gov UEIXMRNG2MNK6F1
CAGE code5L0H4
Incorporated inDE
- portable measure
- muscle composition
- diagnosis
- prognosis
- treatment
- musculoskeletal diseases
- clinicians
- scientists
- caregivers
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationMinority Owned Business
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2018–2022, 3 of them in the five years to SEP 2025.
Medical technology 4
- Enhanced measurements of bioimpedanceUS 11,246,504 · granted FEB 15, 2022
- Advanced electronic instrumentation for electrical impedance myographyUS 11,246,503 · granted FEB 15, 2022
- High performance sensors for electrical impedance myographyUS 11,006,849 · granted MAY 18, 2021
- Sensors, including disposable sensors, for measuring tissueUS 9,861,293 · granted JAN 9, 2018
Granted to Myolex Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Myolex, INC. | Brookline | MA | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.